Molipaxin (Trazodone Hydrochloride)

Trazodone hydrochloride blocks 5‑HT2A receptors while inhibiting serotonin reuptake. This dual mechanism increases the amount of serotonin available at synapses, improving mood regulation and producing antidepressant and anxiolytic effects.

The appropriate dose of Molipaxin is determined by the prescribing clinician based on the individual’s medical condition, response to therapy, and tolerability. Dosage regimens are not standardized and should follow the prescriber’s instructions.

Safety data for trazodone use in pregnancy and lactation are limited. The drug should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the Molipaxin product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Molipaxin (trazodone) belongs to the SARI class, differing from selective serotonin reuptake inhibitors (SSRIs) by also antagonising 5‑HT2A receptors. This profile can result in less sexual dysfunction but may cause more sedation and orthostatic hypotension compared with many SSRIs.

Molipaxin should be stored at room temperature, below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Molipaxin is taken orally, usually with food or a light snack to reduce gastrointestinal irritation. The tablet should be swallowed whole with a glass of water and not crushed, chewed, or split unless specifically instructed by a healthcare professional.

Serious risks include priapism, serotonin syndrome (especially when combined with other serotonergic agents), severe hypotension, cardiac arrhythmias, hepatic injury, and the emergence or worsening of suicidal thoughts. Patients should seek immediate medical attention if any of these occur.

Molipaxin is contraindicated in patients who have taken a monoamine oxidase inhibitor within the past 14 days, those with known hypersensitivity to trazodone, and individuals with a history of priapism. Caution is also advised for patients with severe hepatic impairment or uncontrolled cardiac conditions.